SCHEMBL27224161

SCHEMBL27224161

CCOC(=O)c1[nH]ccc1N(Cc1ccccc1[C@@H]1COCCN1C(=O)O)C(=S)NC(=O)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ LMNA P02545 4/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ SMN1; SMN2 Q16637 6/20 0.32
▸ MAPT P10636 2/20 0.32
▸ ALOX12 P18054 4/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ P2RY12 Q9H244 1/20 0.32
▸ MCOLN3 Q8TDD5 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27224211 1.00 ALDH1A1 (0.37) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL27223562 0.92 ALDH1A1 (0.35) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL30749227 0.92 MEN1 (0.34) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL27223437 0.88 ALDH1A1 (0.35) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL27223621 0.88 ALDH1A1 (0.35) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL30749302 0.84 ALOX15 (0.34) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL27223632 0.84 ALOX15 (0.34) ALDH1A1ALOX15HPGDHSD17B10LMNA
SCHEMBL27224149 0.84 ATM (0.36) ALDH1A1LMNANPSR1MAPTP2RY12
SCHEMBL27223481 0.83 P2RY12 (0.31) ALDH1A1LMNANPSR1SMN1; SMN2MAPT
SCHEMBL27224048 0.83 ALDH1A1 (0.36) ALDH1A1LMNANPSR1SMN1; SMN2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-05-23 — — US disclosed
WO-2024038131-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE MPO, XDH, EPX ALDH1A1 502/4885ALOX15 557/4885HPGD 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback